drugset

drugset / Trial / NCT00683423

BMS-741672 for Diabetic Neuropathic Pain

NCT00683423 ↗

Phase 2 Completed 50 enrolled Bristol-Myers Squibb

RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of the study is to determine whether BMS-741672 improves neuropathic pain in diabetic patients.

Timeline

Start: 2008-07
Primary completion: 2009-01
Completion: 2009-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	BMS-741672	Small molecule	100 mg	Oral

Indications